Latest Sirolimus Stories
Johns Hopkins scientists report having used a commercially available drug to successfully â€œrescueâ€ animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.
UNION CITY, Calif., Oct.
SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ -- The U.S.
NEW YORK, Oct.
Flies fed an "anti-Atkins" low protein diet live longer because their mitochondria function better.
UNION CITY, Calif., Sept. 30 /PRNewswire/ -- MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today provided a clinical development update for Perceiva, the company's proprietary ocular sirolimus product.
SAN FRANCISCO, Sept.
A new type of sirolimus-eluting stent (SES) successfully showed significantly greater neointimal suppression than the paclitaxel-eluting stent (PES) with greater vessel wall integrity surrounding the stent, confirming the finding of superiority of the SES over the PES stent for the trial's primary endpoint of in-stent late loss.
Results of a multicenter study in Asia, demonstrating that drug-eluting stents are effective with a low rate of complications in diabetic patients, will be presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
- Large; stout; burly.